Delivery of the endolysin Cpl-1 by inhalation rescues mice with fatal pneumococcal pneumonia (Q42264677)

19 October 2017

Delivery of the endolysin Cpl-1 by inhalation rescues mice with fatal pneumococcal pneumonia (English)

1 reference

19 October 2017

1 reference

3

Katrin Reppe

1 reference

19 October 2017

11

Martin Witzenrath

1 reference

19 October 2017

Jan M Doehn

1

1 reference

19 October 2017

Katja Fischer

2

1 reference

19 October 2017

Birgitt Gutbier

4

1 reference

19 October 2017

Thomas Tschernig

5

1 reference

19 October 2017

Andreas C Hocke

6

1 reference

19 October 2017

Vincent A Fischetti

7

1 reference

19 October 2017

Jutta Löffler

8

1 reference

19 October 2017

Norbert Suttorp

9

1 reference

19 October 2017

Stefan Hippenstiel

10

1 reference

19 October 2017

language of work or name

English

0 references

publication date

30 April 2013

1 reference

Journal of Antimicrobial Chemotherapy

19 October 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

19 October 2017

68

1 reference

19 October 2017

9

1 reference

19 October 2017

2111-2117

1 reference

Estimates of world-wide distribution of child deaths from acute respiratory infections

19 October 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Bacteriophage endolysins--current state of research and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Comparison of the antibacterial properties of phage endolysins SAL-1 and LysK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

A bacteriolytic agent that detects and kills Bacillus anthracis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Phage Lytic Enzyme Cpl-1 as a Novel Antimicrobial for Pneumococcal Bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Phosphodiesterase 2 inhibition diminished acute lung injury in murine pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Disposition of instilled versus nebulized tobramycin and imipenem in ventilated intensive care unit (ICU) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

The antineutrophil cytoplasmic antibody-associated vasculitides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

The epidemiology of antibiotic resistance in Streptococcus pneumoniae and the clinical relevance of resistance to cephalosporins, macrolides and quinolones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

The lytic enzyme of the pneumococcal phage Dp-1: a chimeric lysin of intergeneric origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT131

21 January 2018

Identifiers

DOI

10.1093/JAC/DKT131

1 reference

release_tw6gr4xctjaofe75orlj66tihe

19 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tw6gr4xctjaofe75orlj66tihe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference